«Dengue

Below is an extended Dengue patents listing. Click here to return to the Dengue main in depth entry.

Patents :
US Patent No.	Title
7411051	Antibodies to HDPPA04 polypeptide
7419787	Mass spectrometric methods for detecting mutations in a target nucleic acid
7419789	Method of inhibiting binding of Dengue virus to a human cell with DC-SIGN blockers
7422746	Chemically programmable immunity
7422853	RNA interference using a universal target
7423010	Nonporous microparticle-prodrug conjugates for treatment of infection
7423119	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7423120	PRO19814 polypeptides
7423127	Antibodies to a polypeptide encoded by a nucleic acid overexpressed in melanoma
7423130	PRO1158 polypeptides
7424318	Dual electrode system for a continuous analyte sensor
7418292	Device and method for attenuating an immune response
7417136	Nucleic acid vaccines for prevention of flavivirus infection
7417125	Antibodies that bind a PRO1158 polypeptide
7413851	Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
7414031	5-nitro-nucleoside compounds for treating viral infections
7416733	Flavivirus fusion inhibitors
7416745	Preventives or remedies for infection, anti-endotoxin agents, vaccine adjuvants and growth promoters
7416840	Replication of hepatitis C virus in non-hepatic epithelial and mouse hepatic cells
7417029	Prodrug of an ice inhibitor
7417115	PRO6027 polypeptides
7417116	PRO7155 polypeptides
7417121	Human G-protein coupled receptor, HGPRBMY39
7417123	PRO4399 Antibodies
7425335	Chimeric T helper-B cell peptide vaccine for Japanese encephalitis virus
7425437	Vaccines against West Nile Virus
7429383	Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
7429455	Methods for genotyping hepatitis C virus
7429571	Therapeutic furopyrimidines and thienopyrimidines
7429572	Modified fluorinated nucleoside analogues
7429640	PRO6181 polypeptides
7429641	PRO9830 polypeptides
7429646	Antibodies to human tumor necrosis factor receptor-like 2
7432046	Methods for the determination of antibody IgG avidity
7432111	Non-continuous immunoassay device and immunoassay method using the same
7432290	Inhibitors of IMPDH enzyme
7429381	Production and use of novel peptide-based agents for use with bi-specific antibodies
7428045	Raman spectral analysis of pathogens
7427667	PRO9835 antibodies
7425605	PRO1486 polypeptides
7425609	PRO4330 polypeptides
7425621	Antibodies against the PRO4401 polypeptide
7425622	Antibodies against C3a receptor
7425635	Prodrugs and conjugates of thiol- and selenol-containing compounds and methods of use thereof
7427468	Anti-TSG101 antibodies and their uses for treatment of viral infections
7427469	Method of treating cytomegalovirus with DC-SIGN blockers
7427471	Modified "S" antibodies
7427605	Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
7427629	Immunostimulatory compositions and methods of stimulating an immune response
7432345	PRO1475 polypeptide

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.